This study provides guidelines on the usefulness of full and 527 bp 16S rRNA gene sequencing and Microseq databases for identifying medically important aerobic Gram-negative bacteria. Overall, full and 527 bp 16S rRNA gene sequencing can identify 26.1 % and 32.6 %, respectively, of medically important aerobic Gram-negative bacteria confidently to the species level, whereas the full-MicroSeq and 500-MicroSeq databases can identify 15.2 % and 26.1 %, respectively, of medically important aerobic Gram-negative bacteria confidently to the species level. Among the major groups of aerobic Gram-negative bacteria, the methods and databases are least useful for identification of Aeromonas, Bordetella and Bartonella species. None of the Aeromonas species can be confidently or doubtfully identified, whereas only 0 % and 0-33.3 % of Bordetella species and 0-10 % and 0-10 % of Bartonella species can be confidently and doubtfully identified, respectively. On the other hand, these methods and databases are most useful for identification of members of the families Pasteurellaceae and Legionellaceae and Campylobacter species: 29.6-59.3 % and 7.4-18.5 % of members of Pasteurellaceae, 36-52 % and 12-24 % of members of Legionellaceae, and 26.7-60 % and 0-13.3 % of Campylobacter species can be confidently and doubtfully identified, respectively. Thirty-nine medically important aerobic Gram-negative bacteria that should be confidently identified by full 16S rRNA gene sequencing are not included in the full-MicroSeq database. Twenty-three medically important aerobic Gram-negative bacteria that should be confidently identified by 527 bp 16S rRNA gene sequencing are not included in the 500-MicroSeq database. Compared with results of our previous studies on anaerobic and Gram-positive bacteria, full and 527 bp 16S rRNA gene sequencing are able to confidently identify significantly more anaerobic Gram-positive and Gramnegative bacteria than aerobic Gram-positive and Gram-negative bacteria.
INTRODUCTION
Since its first use 30 years ago, 16S rRNA gene sequencing has played a pivotal role in bacterial classification and discovery of novel bacteria (Woo et al., 2008) . In the last decade, as a result of the widespread use of PCR and DNA sequencing, this technology has been increasingly applied for identification of medically important bacteria (Lau et al., 2002 (Lau et al., , 2004 Teng et al., 2003; Woo et al., 2001a Woo et al., , b, 2002 Woo et al., , 2003a Woo et al., , 2004 Woo et al., , 2005 Yuen et al., 2001) . Although 16S rRNA gene sequencing has been widely used in reference laboratories, one of the major limitations to its wider use in routine clinical microbiology laboratories is the difficulty associated with interpretation of 16S rRNA gene sequence results. The use of 16S rRNA gene sequencing for bacterial identification depends on significant inter-species differences and small intra-species differences in 16S rRNA gene sequences. As a result, one of the major limitations is that when two bacterial species share a similar 16S rRNA gene sequence, this technology alone would not be useful for distinguishing them confidently. This limitation has also generated the main obstacle for clinical microbiologists and technicians when they interpret BLAST results generated from their 16S rRNA gene sequence data. Misinterpretation of such data will lead to incorrect identification of bacteria, which defeats the original purpose of 16S rRNA gene sequencing.
With the aim of facilitating 16S rRNA gene sequence interpretation, the MicroSeq 500 16S rRNA bacterial identification system (version 2.1) (MicroSeq, Applied Biosystems) has been designed. The 500-MicroSeq database can be used to analyse a 527 bp fragment amplified and sequenced from the 59 end of the 16S rRNA gene (Fontana et al., 2005; Lau et al., 2006; Tang et al., 1998; Woo et al., 2003b) . A full 16S rRNA gene sequence (full-MicroSeq) database (version 2.0) has also been generated. Nevertheless, the MicroSeq databases do not take account of bacterial species sharing similar 16S rRNA gene sequences that cannot be confidently identified by 16S rRNA gene sequence analysis. Another drawback for identification of medically important bacteria is that the MicroSeq databases do not include a significant number of medically important bacteria that 16S rRNA gene sequencing is able to identify.
In view of these limitations, 5 years ago we started to systematically evaluate the usefulness of full and 527 bp 16S rRNA gene sequencing and the MicroSeq databases for identification of various groups of medically important bacteria. In the last 4 years, we have published the results for medically important anaerobes and aerobic Grampositive bacteria, respectively (Woo et al., 2007 (Woo et al., , 2009 ). We found that 53.3-67.1 % and 22.7-37.3 % of medically important anaerobic and aerobic Gram-positive bacteria that should be confidently identified by 16S rRNA gene sequencing are not included in the full-and 500-MicroSeq databases, respectively (Woo et al., 2007 (Woo et al., , 2009 . In this article, we describe the results of the evaluation of the usefulness of full and 527 bp 16S rRNA gene sequencing and the MicroSeq databases for identification of 328 medically important aerobic Gram-negative bacteria. The usefulness of full and 527 bp 16S rRNA gene sequencing and the MicroSeq databases for identification of aerobic Gram-positive bacteria, aerobic Gram-negative bacteria, anaerobic Gram-positive bacteria and anaerobic Gramnegative bacteria was also compared.
METHODS
16S rRNA gene sequences of medically important aerobic Gram-negative bacteria. The species of medically important aerobic Gram-negative bacteria included in this study include all 32 species of the 13 genera of Alphaproteobacteria, 67 species of the 19 genera of Betaproteobacteria, 195 species of the 55 genera of Gammaproteobacteria, two species of the one genus of Deltaproteobacteria and 32 species of the three genera of Epsilonproteobacteria listed in the most recent edition of the Manual of Clinical Microbiology (Murray et al., 2007) . For each bacterial species, a list of the 16S rRNA gene sequences was retrieved from the GenBank database (release 179.0). In the list, the most representative 16S rRNA gene sequence for each species was chosen for analysis according to the following criteria: (a) strains with good phenotypic and/or genotypic characterization (e.g. type strains, strains with complete genomes sequenced) were preferred; (b) strains isolated from humans were preferred to those isolated from animals or the environment; (c) sequences with fewer undetermined bases were preferred to those with more undetermined bases; and (d) longer sequences, especially those with better coverage of the 59 end, were preferred to shorter sequences and those with poorer coverage of the 59 end.
Comparison of full 16S rRNA gene sequences of medically important aerobic Gram-negative bacteria. The percentage differences of the 16S rRNA gene sequences among the different species in the same group/genus of medically important aerobic Gram-negative bacteria were determined by pairwise alignment using CLUSTAL W.
Comparison of 527 bp 16S rRNA gene sequences of medically important aerobic Gram-negative bacteria. The 527 bp sequences that should be amplified by the primers of MicroSeq and analysed in the 500-MicroSeq database were extracted from the full 16S rRNA gene sequences. The percentage differences of the resultant partial 16S rRNA gene sequences among the different species in the same group/ genus of medically important aerobic Gram-negative bacteria were determined by pairwise alignment using CLUSTAL W.
MicroSeq databases. All medically important aerobic Gramnegative bacteria listed in the most recent edition of the Manual of Clinical Microbiology (Murray et al., 2007) were searched in the 500-MicroSeq database (version 2.1) and full-MicroSeq databases (version 2.0) (MicroSeq, Applied Biosystems).
Definitions. In this study, a bacterial species is defined as 'can be confidently identified by 16S rRNA gene sequencing' if there is .3 % difference between the 16S rRNA gene sequence of the species and those of other medically important bacterial species. A bacterial species is defined as 'cannot be confidently identified by 16S rRNA gene sequencing' if there is ,2 % difference between the 16S rRNA gene sequence of the species and that of one or more medically important aerobic Gram-negative bacterial species. A bacterial species is defined as 'can only be doubtfully identified by 16S rRNA gene sequencing' if there is 2-3 % difference between the 16S rRNA gene sequence of the species and that of one or more medically important aerobic Gram-negative bacterial species.
RESULTS
Full 16S rRNA gene sequencing should be useful for the identification of 8 of 32 Alphaproteobacteria (none of 10 Bartonella species), 18 of 67 Betaproteobacteria (none of 9 Bordetella species, 1 of 13 Burkholderia species and 3 of 12 Neisseria species), 50 members of 195 Gammaproteobacteria (none of the members of 10 Aeromonadaceae, 6 members of 83 Enterobacteriaceae, 10 members of 25 Legionellaceae, 16 members of 27 Pasteurellaceae, 3 members of 17 Moraxellaceae, 4 members of 11 Pseudomonadaceae and 4 members of 12 Vibrionaceae), none of 2 Deltaproteobacteria (none of 2 Desulfovibrio species) and 10 members of 32 Epsilonproteobacteria (7 of 15 Campylobacter species and 2 of 11 Helicobacter species). For the existing full-MicroSeq database, it should be useful for the identification of 4 members of 32 Alphaproteobacteria (none of 10 Bartonella species), 9 members of 67 Betaproteobacteria (none of 9 Bordetella species, none of 13 Burkholderia species and 3 of 12 Neisseria species), 34 members of 195 Gammaproteobacteria (none of the members of 10 Aeromonadaceae, 6 members of 83 Enterobacteriaceae, 9 members of 25 Legionellaceae, 8 members of 27 Pasteurellaceae, 1 member of 17 Moraxellaceae, 3 members of 11 Pseudomonadaceae and 2 members of 12 Vibrionaceae), none of 2 Deltaproteobacteria (none of 2 Desulfovibrio species) and 6 members of 32 Epsilonproteobacteria (4 of 15 Campylobacter species and 1 of 11 Helicobacter species).
The 527 bp 16S rRNA gene sequencing should be useful for the identification of 8 members of 32 Alphaproteobacteria (1 of 10 Bartonella species), 25 members of 67 Betaproteobacteria (none of 9 Bordetella species, 2 of 13 Burkholderia species and 5 of 12 Neisseria species), 64 members of 195 Gammaproteobacteria (none of the members of 10 Aeromonadaceae, 13 members of 83 Enterobacteriaceae, 13 members of 25 Legionellaceae, 16 members of 27 Pasteurellaceae, 5 members of 17 Moraxellaceae, 5 members of 11 Pseudomonadaceae and 5 members of 12 Vibrionaceae), 2 of 2 Deltaproteobacteria (2 of 2 Desulfovibrio species) and 10 members of 32 Epsilonproteobacteria (9 of 15 Campylobacter species and 1 of 11 Helicobacter species). For the existing 500-MicroSeq database, it should be useful for the identification of 5 members of 32 Alphaproteobacteria (1 of 10 Bartonella species), 19 members of 67 Betaproteobacteria (none of 9 Bordetella species, 2 of 13 Burkholderia species and 5 of 12 Neisseria species), 60 members of 195 Gammaproteobacteria (none of the members of 10 Aeromonadaceae, 13 members of 83 Enterobacteriaceae, 12 members of 25 Legionellaceae, 15 members of 27 Pasteurellaceae, 5 members of 17 Moraxellaceae, 5 members of 11 Pseudomonadaceae and 5 members of 12 Vibrionaceae), none of 2 Deltaproteobacteria (none of 2 Desulfovibrio species) and 7 members of 32 Epsilonproteobacteria (6 of 15 Campylobacter species and 1 of 11 Helicobacter species) ( Table 1 and Supplementary Tables S1-S8 , available with the online version of this paper).
DISCUSSION
In this and two previous studies, we systematically analysed the usefulness and degree of confidence in using 16S rRNA gene sequence for identification of medically important bacterial species (Woo et al., 2007 (Woo et al., , 2009 ). Since different bacterial species are likely to evolve at different rates, there has been no agreement on a universal cut-off for bacterial species delineation when 16S rRNA gene sequencing is used for their identification. In the literature, different cutoffs, ranging from 97 % to 99.5 % nucleotide identity, have been arbitrarily used by various groups. Stackebrandt & Goebel (1994) proposed 97 % nucleotide identity in the 16S rRNA gene as the cut-off for bacterial speciation. Drancourt et al. (2000) employed .99 % and .97 % nucleotide identity as the cut-off for species and genus identification respectively. However, these sharp cut-offs were only made for practical purposes for interpretation of their large sequence dataset. On the other hand, Janda & Abbott (2007) suggested that a minimum of .99 %, and ideally .99.5 %, nucleotide identity be used for bacterial species identification. In the present study and two previous ones (Woo et al., 2007 (Woo et al., , 2009 ), we used .3 %, 2-3 % and ,2 % difference between the most representative 16S rRNA gene sequence of bacterial species obtained from GenBank and those of other medically important bacteria to indicate the degree of confidence when using 16S rRNA gene sequence for identification of medically important bacterial species. For example, for aerobic Gram-negative bacteria, the percentage of most groups of bacteria, including Bordetella, Neisseria, Enterobacteriaceae, Legionellaceae, Pasteurellaceae, Moraxellaceae, Pseudomonadaceae, Vibrionaceae, Deltaproteobacteria, Campylobacter and Helicobacter, that can be identified would increase if a cut-off of 2 % instead of 3 % was used ( Supplementary  Fig. S1 ). Similarly the percentage of most groups of bacteria, including Burkholderia, Neisseria, Enterobacteriaceae, Legionellaceae, Pasteurellaceae, Moraxellaceae, Pseudomonadaceae, Vibrionaceae, Campylobacter and Helicobacter, that can be identified would decrease if a cut-off of 4 % instead of 3 % was used (Fig. S1 ). When there is 2-3 % difference between the 16S rRNA gene sequence of a bacterial species and a closely related one, the degree of 16S rRNA gene sequence homogeneity in different strains of the species would be very important in determining whether 16S rRNA gene sequencing is able to identify the bacterium to the species level. The only group of bacteria for which the percentage of identification is not affected by either an increase or a decrease in the cut-off is Aeromonadaceae (Fig.  S1 ). This is because all Aeromonas species shared .99 % identities in their 16S rRNA gene sequences. Such guidelines for clinical microbiologists and technicians are important because if the first hit by BLASTN search against the GenBank database is used for deciding the identity of a 16S rRNA gene sequence, a significant amount of the searches will give wrong or ambiguous results. For example, the first hit of 15 (18.1 %) of the 83 Enterobacteriaceae members by BLASTN search using our representative 16S rRNA gene sequences was of a wrong species (five were of a wrong genus) and another 15 (18.1 %) gave ambiguous results, even after filtering off all 'uncultured/environmental sample sequences'.
16S rRNA gene sequencing is more useful for identification of medically important anaerobic bacteria than aerobic bacteria. Comparing the results of the present study and our two previous ones on medically important anaerobes and aerobic Gram-positive bacteria (Woo et al., 2007 (Woo et al., , 2009 , 16S rRNA gene sequencing is found to be able to confidently identify significantly more anaerobic Grampositive (62.4 %) and Gram-negative (75 %) bacteria than aerobic Gram-positive (26.8 %) and Gram-negative (26.1 %) bacteria (Table 2) . A similar phenomenon was also observed when the first 527 bp of the 16S rRNA genes were analysed (Table 2) . On the other hand, for both the full-and 500-MicroSeq databases, their usefulness for identification of anaerobic Gram-positive and Gramnegative bacteria was only slightly better than for aerobic Gram-positive and Gram-negative bacteria (Table 2 ). This is because there are more anaerobic Gram-positive and Gram-negative bacteria that should be identifiable by full or 527 bp 16S rRNA gene sequencing but are not included in the full-and 500-MicroSeq databases (Tables 2 and 3) . Notably, 527 bp 16S rRNA gene sequencing can always identify more bacteria than full 16S rRNA gene sequencing, and the 500-MicroSeq database can always identify more bacteria than the full-MicroSeq database for all groups of bacteria. This is because the 59 527 bp of the 16S rRNA gene is more variable than the other parts of the gene. literature (Tang et al., 1998; Simmon et al., 2006) . This is mainly because the MicroSeq databases do not take into account bacteria with similar 16S rRNA gene sequences, which can confuse the identity of the bacterium. In fact, it is well known that the 16S rRNA gene is probably not the best target for identifying Aeromonas and Bartonella species and members of the Enterobacteriaceae, and alternative gene targets, such as gyrB, rpoB, gltA and dnaJ, have been used for their identification.
